AMGN
AMGN stands for Amgen Inc., a leading biotechnology company focused on discovering, developing, and delivering innovative human therapeutics.
Asset Summary
Loading summary…
Asset Performance Metrics and Risk Characteristics:
Metrics below use daily returns for Jan 1, 2026 – Sep 10, 2026 (YTD).
Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.
1 Month Trailing Return
-6.22%
Represents the percentage change in asset value over the past month.
3 Month Trailing Return
15.85%
Indicates the percentage change in asset value over the last three months.
Period Max Drawdown
16.57%
The highest percentage drop from the peak value to the lowest point during the observed period.
Standard Deviation
30.32%
Shows how much the asset’s daily returns deviate from the average, annualized for the entire period.
Sharpe Ratio
1.01
Measures the average return earned in excess of the risk-free rate per unit of volatility, annualized.
Calmar Ratio
1.85
The ratio of the annualized return to the maximum drawdown, reflecting the return per unit of risk.
Asset Technical Analysis
Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.
Analysis
Moving Averages
Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:
| Type/Period | |
|---|---|
| SMA | |
| EMA | |
| WMA | |
| WEMA |
- SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
- EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
- WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
- WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.
Enhance Your AMGN Trading Now
Experience the future of trading with ohlcx.com. Our advanced system delivers in-depth analysis and insights for AMGN, utilizing state-of-the-art technical tools and strategies. Boost your investment success with us and see how we can elevate your trading results!
Boost Performance NowFrequently Asked Questions
-
Amgen develops innovative medicines that address serious diseases, improving patient outcomes and enhancing the quality of life for patients globally.
-
Historically, AMGN has shown strong performance and resilience, reflecting the growth trends in the biotechnology sector.
-
Investing in AMGN may be attractive if you believe in the growth potential of the biotechnology sector, but potential investors should conduct thorough research.
-
Amgen is recognized for its robust research pipeline, innovative therapies, and commitment to quality in biopharmaceuticals.
-
Amgen is headquartered in Thousand Oaks, California, USA.
-
Risks include regulatory challenges, competition from generic drugs, and the volatility associated with biotechnology stocks.
-
Amgen’s key products include therapies for cancer, kidney disease, rheumatoid arthritis, and other serious medical conditions, such as Neulasta and Enbrel.
-
Amgen has a history of paying dividends and aims to provide consistent returns to its shareholders while also investing in research and development.
-
Amgen generates revenue primarily through the sale of its biologic drugs and therapies, as well as licensing agreements and partnerships with other companies.
-
Amgen reports its financial results on a quarterly and annual basis, offering insights into its earnings and business operations.
Top Market Assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Asset Related News
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.